Identifying high-risk subtypes and risk factors for recurrence in Merkel cell carcinoma: A single-institution retrospective study - 18/02/26
Doi : 10.1016/j.jaad.2025.11.024
Yingjoy Li, BA a, Kenneth G. Linden, MD, PhD b, James G. Jakowatz, MD c, Maki Yamamoto, MD c, Thuy B. Tran, MD c, ⁎ 
a University of California, Irvine School of Medicine, Irvine, California
b Department of Dermatology, University of California, Irvine, California
c Division of Surgical Oncology, Department of Surgery, University of California, Orange, California
∗ Correspondence to: Thuy B. Tran, MD, Division of Surgical Oncology, Department of Surgery, University of California, 3800 W, Chapman Ave, Suite 6200, Orange 92868, CA Division of Surgical Oncology Department of Surgery University of California 3800 W Chapman Ave Suite 6200 Orange CA 92868
Key words : combined Merkel cell carcinoma, disease relapse, Merkel cell carcinoma, prognostic factors, recurrence, recurrence-free survival, retrospective study, risk factors
| Funding sources: None. |
|
| Patient consent: IRB waiver for informed consent was obtained. |
|
| IRB approval status: Reviewed and approved by University of California, Irvine IRB (#1680). |
© 2025
American Academy of Dermatology, Inc.. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 94 - N° 3
P. 984-986 - mars 2026 Retour au numéro
Article précédent
- ELISA-detected salivary Treponema pallidum antibodies for predicting neurosyphilis risk: A retrospective multicenter cohort study
- Wei-Peng Lin, Ling Yang, Ze-Jun Luo, Jia-Hui Shen, Zu-Ping Song, An-Ni Lin, Yu-Zhen Chen, Jia-Wen Wei, Krishna Hamal, Ming Liang, Di Yang, Sichan Wu, Xueying Zhong, Zhenwu Yuan, Yuyang Jiang, Xiaomei Luo, Dong-Hua Liu
- Risk of pediatric infections following dupilumab treatment for atopic dermatitis: A TriNetX cohort study
- Henry O. Herrera, Jeremy S. Bordeaux
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?